Phase 1 Open-Label study of the pharmacokinetics and safety of a single-dose of ZTI-01 (Fosfomycin for injection) in Pediatric subjects <12 years of age receiving standard of care antibiotic therapy for proven or suspected infection or for peri-operative prophylaxis